YS Biopharma Co., Ltd. - LSB Net Assets per Single Share

LakeShore Biopharma Co. (LSB) strategy for the globalization of innovative vaccines defines the current trend, while BVPS dynamics on GURU.Markets are recorded around 0.00. Margin growth here depends on scaling government contracts to reduce the share of Capex, although restrained investor sentiment is driven by a management restructuring. This book value per share chart visualizes the actual preservation of the company's capital.

Accounting Value of a Share: LakeShore Biopharma Co., Ltd. (LSB) for 05/29/2024 - 10/04/2025

ysbiopharm.com - analytical breakdowns and key metrics (LSB)

- price and consensus price forecast:

Stock Price YS Biopharma|LSB - Price Target Chart

- market capitalization data:

Market Value LakeShore Biopharma Co., Ltd.|LSB - Full Business Value

- book capitalization data:

Book Value per Share LakeShore Biopharma|LSB - Accounting Value of Company|Market Capitalization to Book Value Ratio ysbiopharm.com|LSB - Company Total Assets

- debt and liquidity data:

Debt to Equity LakeShore Biopharma Co.|LSB - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity LakeShore Biopharma|LSB - Company Total Debt|Debts to Book Capitalization LakeShore Biopharma Co., Ltd.

Analysis of all company metrics:YS Biopharma (LSB)

Signature product of LakeShore Biopharma

Book value per share reflects the portion of equity attributable to a single security after deducting all liabilities, serving as an indicator of the actual value of assets. The trend in this key book value metric demonstrates the efficiency of resource capitalization, which for the rabies vaccine market leader, LakeShore Biopharma Co. (LSB), confirms financial stability driven by steady cash flows from the sale of critical medications.

Competitor analysis